A detailed history of Autus Asset Management, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Autus Asset Management, LLC holds 63,065 shares of EW stock, worth $4.23 Million. This represents 0.85% of its overall portfolio holdings.

Number of Shares
63,065
Previous 64,171 1.72%
Holding current value
$4.23 Million
Previous $5.3 Million 11.26%
% of portfolio
0.85%
Previous 1.02%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 23, 2023

SELL
$68.3 - $87.44 $75,539 - $96,708
-1,106 Reduced 1.72%
63,065 $0
Q3 2022

Oct 13, 2022

SELL
$82.37 - $107.29 $10,955 - $14,269
-133 Reduced 0.21%
64,171 $5.3 Million
Q2 2022

Jul 22, 2022

SELL
$86.5 - $128.27 $116,256 - $172,394
-1,344 Reduced 2.05%
64,304 $6.11 Million
Q1 2022

Apr 13, 2022

SELL
$101.96 - $128.34 $3.44 Million - $4.33 Million
-33,706 Reduced 33.93%
65,648 $7.73 Million
Q4 2021

Jan 14, 2022

SELL
$106.37 - $130.68 $203,698 - $250,252
-1,915 Reduced 1.89%
99,354 $12.9 Million
Q3 2021

Oct 18, 2021

SELL
$102.91 - $122.75 $272,094 - $324,551
-2,644 Reduced 2.54%
101,269 $11.5 Million
Q2 2021

Jul 16, 2021

SELL
$83.84 - $104.76 $293,188 - $366,345
-3,497 Reduced 3.26%
103,913 $10.8 Million
Q1 2021

Apr 14, 2021

BUY
$78.68 - $90.67 $577,589 - $665,608
7,341 Added 7.34%
107,410 $8.98 Million
Q4 2020

Jan 19, 2021

SELL
$71.69 - $91.23 $1 Million - $1.27 Million
-13,949 Reduced 12.23%
100,069 $9.13 Million
Q3 2020

Oct 13, 2020

SELL
$67.19 - $87.44 $31,646 - $41,184
-471 Reduced 0.41%
114,018 $9.1 Million
Q2 2020

Jul 16, 2020

BUY
$57.54 - $76.95 $4.39 Million - $5.87 Million
76,291 Added 199.73%
114,489 $7.91 Million
Q1 2020

Apr 16, 2020

SELL
$52.41 - $81.0 $68,814 - $106,353
-1,313 Reduced 3.32%
38,198 $7.21 Million
Q4 2019

Jan 24, 2020

SELL
$71.7 - $82.09 $15,128 - $17,320
-211 Reduced 0.53%
39,511 $9.22 Million
Q3 2019

Nov 12, 2019

SELL
$61.55 - $75.43 $139,287 - $170,698
-2,263 Reduced 5.39%
39,722 $8.74 Million
Q2 2019

Jul 15, 2019

SELL
$55.74 - $64.41 $2,564 - $2,962
-46 Reduced 0.11%
41,985 $7.76 Million
Q1 2019

Apr 16, 2019

SELL
$47.89 - $64.05 $67,141 - $89,798
-1,402 Reduced 3.23%
42,031 $8.04 Million
Q4 2018

Feb 11, 2019

SELL
$46.41 - $56.94 $34,853 - $42,761
-751 Reduced 1.7%
43,433 $6.65 Million
Q3 2018

Oct 26, 2018

SELL
$45.7 - $58.03 $42,226 - $53,619
-924 Reduced 2.05%
44,184 $7.69 Million
Q2 2018

Aug 03, 2018

SELL
$42.45 - $51.3 $50,642 - $61,200
-1,193 Reduced 2.58%
45,108 $6.57 Million
Q1 2018

Apr 24, 2018

SELL
$37.19 - $47.45 $75,718 - $96,608
-2,036 Reduced 4.21%
46,301 $6.46 Million
Q4 2017

Feb 01, 2018

SELL
$33.79 - $39.39 $14,191 - $16,543
-420 Reduced 0.86%
48,337 $5.45 Million
Q3 2017

Nov 08, 2017

BUY
$36.29 - $38.83 $3,919 - $4,193
108 Added 0.22%
48,757 $5.33 Million
Q2 2017

Aug 09, 2017

BUY
N/A
48,649
48,649 $5.75 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.4B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Autus Asset Management, LLC Portfolio

Follow Autus Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Autus Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Autus Asset Management, LLC with notifications on news.